| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 131, 398-403, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
T Doi, LJ Striker, C Quaife, FG Conti, R Palmiter, R Behringer, R Brinster and GE Striker
Metabolic Diseases Branch, NIDDK, Bethesda, MD 20892.
An increase in glomerular size occurs in normal maturation after subtotal renal ablation and disease states such as diabetes mellitus. The role that growth hormone (GH), growth hormone releasing factor (GHRF), and insulinlike growth factor-1 (IGF-1) play in these processes has been investigated using transgenic mice chronically expressing these hormones. The glomeruli were enlarged in all 3 strains of mice. Mesangial proliferation followed by progressive glomerulosclerosis was observed in the GH and GHRF animals only. In the IGF-1 mice the large glomeruli remained morphologically normal except for the enlargement. These data suggest that the glomerulosclerosis was due, in part, to disordered mesangial cell growth in response to circulating GH. The mesangial lesions in mice with chronically high plasma GH levels mimicked those in human diabetes mellitus. These models provide a means to study the hormonal regulation of glomerular growth and the role that specific hormones might play in the pathogenesis of glomerulosclerosis.
This article has been cited by other articles:
 |
|
 |
|
  J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.-P. Girolami ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1083 - F1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression J. Endocrinol., June 1, 2007; 193(3): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, et al. RAGE Control of Diabetic Nephropathy in a Mouse Model: Effects of RAGE Gene Disruption and Administration of Low-Molecular Weight Heparin Diabetes, September 1, 2006; 55(9): 2510 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. H. Schenck and C. L. Brooks Effects of an S84E Mutation of Bovine Growth Hormone in Transgenic Mice. Experimental Biology and Medicine, March 1, 2006; 231(3): 296 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Feng, A. R. Plati, Q.-l. Cheng, M. Berho, A. Banerjee, M. Potier, W.-c. Jy, A. Koff, L. J. Striker, and G. E. Striker Glomerular Aging in Females Is a Multi-Stage Reversible Process Mediated by Phenotypic Changes in Progenitors Am. J. Pathol., August 1, 2005; 167(2): 355 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zheng, Q.-L. Cheng, A.-R. Plati, S. Q. Ye, M. Berho, A. Banerjee, M. Potier, E. A. Jaimes, H. Yu, Y.-F. Guan, et al. The Glomerulosclerosis of Aging in Females: Contribution of the Proinflammatory Mesangial Cell Phenotype to Macrophage Infiltration Am. J. Pathol., November 1, 2004; 165(5): 1789 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Gooch, Y. Tang, J. M. Ricono, and H. E. Abboud Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism J. Biol. Chem., November 2, 2001; 276(45): 42492 - 42500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bohlooly-Y, L. Carlson, B. Olsson, H. Gustafsson, I. J. L. Andersson, J. Tornell, and G. Bergstrom Vascular Function and Blood Pressure in GH Transgenic Mice Endocrinology, August 1, 2001; 142(8): 3317 - 3323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. ROELFSEMA and R. G. CLARK The Growth Hormone and Insulin-Like Growth Factor Axis: Its Manipulation for the Benefit of Growth Disorders in Renal Failure J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1297 - 1306. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. P. Keenan, J. B. Coleman, C. L. Mccoy, C.-M. Hoe, K. A. Soper, and P. Laroque Chronic Nephropathy in Ad Libitum Overfed Sprague-Dawley Rats and Its Early Attenuation by Increasing Degrees of Dietary (Caloric) Restriction to Control Growth Toxicol Pathol, November 1, 2000; 28(6): 788 - 798. [Abstract] [PDF]
|
|
|
|
|
|
J. HAYLOR, H. HICKLING, E. EL ETER, A. MOIR, S. OLDROYD, C. HARDISTY, and A. M. EL NAHAS JB3, an IGF-I Receptor Antagonist, Inhibits Early Renal Growth in Diabetic and Uninephrectomized Rats J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2027 - 2035. [Abstract] [Full Text]
|
|
|
|
|
|
M. KASAHARA, M. MUKOYAMA, A. SUGAWARA, H. MAKINO, T. SUGANAMI, Y. OGAWA, M. NAKAGAWA, K. YAHATA, M. GOTO, R. ISHIBASHI, et al. Ameliorated Glomerular Injury in Mice Overexpressing Brain Natriuretic Peptide with Renal Ablation J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1691 - 1701. [Abstract] [Full Text]
|
|
|
|
|
|
S. Q. DOI, T. A. JACOT, D. F. SELLITTI, P. HIRSZEL, M. H. HIRATA, G. E. STRIKER, and L. J. STRIKER Growth Hormone Increases Inducible Nitric Oxide Synthase Expression in Mesangial Cells J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1419 - 1425. [Abstract] [Full Text]
|
|
|
|
|
|
S. Molon-Noblot, P. Laroque, S. Prahalada, L. G. Stabinski, C. P. Peter, P. Duprat, and M. J. Van Zwieten Morphological Changes in the Kidney of Dogs Chronically Exposed to Exogenous Growth Hormone Toxicol Pathol, July 1, 2000; 28(4): 510 - 517. [Abstract] [PDF]
|
|
|
|
|
|
L. L. Bellush, S. Doublier, A. N. Holland, L. J. Striker, G. E. Striker, and J. J. Kopchick Protection against Diabetes-Induced Nephropathy in Growth Hormone Receptor/Binding Protein Gene-Disrupted Mice Endocrinology, January 1, 2000; 141(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. ZAOUI, E. ROSSINI, N. PINEL, D. CORDONNIER, S. HALIMI, and F. MOREL High Fructose-Fed Rats: A Model of Glomerulosclerosis Involving The Renin-Angiotensin System and Renal Gelatinases Ann. N.Y. Acad. Sci., June 30, 1999; 878(1): 716 - 719. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Seikaly, R. Brown, and M. Baum The Effect of Recombinant Human Growth Hormone in Children With X-Linked Hypophosphatemia Pediatrics, November 1, 1997; 100(5): 879 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-y. Chen, W. Y. Chen, and J. J. Kopchick Liver and Kidney Growth Hormone (GH) Receptors Are Regulated Differently in Diabetic GH and GH Antagonist Transgenic Mice Endocrinology, May 1, 1997; 138(5): 1988 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pursel, C. Pinkert, K. Miller, D. Bolt, R. Campbell, R. Palmiter, R. Brinster, and R. Hammer Genetic engineering of livestock Science, June 16, 1989; 244(4910): 1281 - 1288. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
